المؤلفون: Jorge Camarero, Filip Josephson, Maja Sommerfelt Grønvold, Nikolaos Zafiropoulos, Sahra Ali, Paula van Hennik, Christian Syvertsen, Bjorn Oddvar Strøm, Mats Ökvist, Brigitte Keller-Stanislawski, Elias Pean, Silvy da Rocha Dias, Franscesco Pignatti

المصدر: ESMO Open, Vol 5, Iss 6 (2020)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://esmoopen.bmj.com/content/5/6/e000798.fullTest; https://doaj.org/toc/2059-7029Test

الوصول الحر: https://doaj.org/article/6b829280fb9f45478adefcbc1a162bb8Test

المؤلفون: Daniela Melchiorri, Jonas Bergh, Francesco Pignatti, Didier Meulendijks, Paula Hennik, Bjorg Bolstad, Luca Moscetti, Jorge Camarero, Filip Josephson, Maja Sommerfelt Grønvold, Jan Sjoberg, Mihaela Botezatu, Jorn Mulder, Ana Trullas Jimeno, Nikolaos Zafiropoulos, Harald Enzmann

المصدر: ESMO Open, Vol 5, Iss 4 (2020)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://esmoopen.bmj.com/content/5/4/e000856.fullTest; https://doaj.org/toc/2059-7029Test

الوصول الحر: https://doaj.org/article/7a7953d10b004678ab44dca70ec3f5f2Test

المؤلفون: Jonas Bergh, Jorn Mulder, Mihaela Botezatu, Luca Moscetti, Filip Josephson, Ana Trullas Jimeno, Nikolaos Zafiropoulos, Paula van Hennik, Jan Sjöberg, Daniela Melchiorri, Harald Enzmann, Didier Meulendijks, Francesco Pignatti, Maja Sommerfelt Grønvold, Bjorg Bolstad, Jorge Camarero

المصدر: ESMO Open
ESMO Open, Vol 5, Iss 4 (2020)

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, EMA, European Medicine Agency, regulatory, renal cell cancer, Axitinib, Humans, Ipilimumab, Nivolumab, Carcinoma, Renal Cell, Kidney Neoplasms, medicine.drug_class, Pembrolizumab, Review, lcsh:RC254-282, Tyrosine-kinase inhibitor, law.invention, Avelumab, law, Internal medicine, Medicine, media_common.cataloged_instance, European union, media_common, Clinical pharmacology, business.industry, Carcinoma, Renal Cell, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93da749197f6dc09a9c7c8e371fbfb64Test
http://europepmc.org/articles/PMC7451283Test

المؤلفون: Jonas Bergh, Filip Josephson, Bjorg Bolstad, Maja Sommerfelt Grønvold, Christian Syvertsen, Bjorn Oddvar Strøm, Mats Ökvist, Nikolaos Zafiropoulos, Sahra Ali, Elias Pean, Franscesco Pignatti, Paula van Hennik, Jorge Camarero, Silvy da Rocha Dias, Brigitte Keller-Stanislawski

المصدر: ESMO Open
ESMO Open, Vol 5, Iss 6 (2020)

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Cancer drugs, Ipilimumab, Antineoplastic Agents, Review, urologic and male genital diseases, lcsh:RC254-282, renal cell carcinoma (RCC), Renal cell carcinoma, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Combination immunotherapy, Carcinoma, Renal Cell, Randomized Controlled Trials as Topic, Poor risk, business.industry, Sunitinib, Committee for Medical Product for Human Use (CHMP), European Medicines Agency (EMA), overall survival (OS), medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Kidney Neoplasms, Radiation therapy, Nivolumab, metastatic RCC (mRCC), Immunotherapy, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7b099a2cc0140ca2110d40465e2ea62Test
https://pubmed.ncbi.nlm.nih.gov/33188050Test